Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.034 CHF
1.34 B CHF
11.99 B CHF
1.47 B
About Boston Scientific Corporation
Sector
Industry
CEO
Michael F. Mahoney
Website
Headquarters
Marlborough
Founded
1979
FIGI
BBG00LVDCSH7
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049Yield to maturity
5.57%
Maturity date
Mar 1, 2049
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039Yield to maturity
5.48%
Maturity date
Mar 1, 2039
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030Yield to maturity
5.11%
Maturity date
Jun 1, 2030
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040Yield to maturity
5.01%
Maturity date
Jan 15, 2040
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029Yield to maturity
4.88%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028Yield to maturity
4.86%
Maturity date
Mar 1, 2028
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026Yield to maturity
4.78%
Maturity date
Mar 1, 2026
BSX4988125
Boston Scientific Corporation 1.9% 01-JUN-2025Yield to maturity
4.75%
Maturity date
Jun 1, 2025
CH0A
AMERICAN MEDICAL SYSTEMS EUROPE B.V. 2022-08.03.34 GUARANTEEDYield to maturity
3.53%
Maturity date
Mar 8, 2034
Explore more bonds
Frequently Asked Questions
The current price of BSX is 80.995 CHF — it has increased by 3.48% in the past 24 hours. Watch BOSTON SCIENTIFIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange BOSTON SCIENTIFIC stocks are traded under the ticker BSX.
BSX stock has risen by 3.48% compared to the previous week, the month change is a 3.48% rise, over the last year BOSTON SCIENTIFIC has showed a 71.23% increase.
We've gathered analysts' opinions on BOSTON SCIENTIFIC future price: according to them, BSX price has a max estimate of 97.48 CHF and a min estimate of 76.22 CHF. Watch BSX chart and read a more detailed BOSTON SCIENTIFIC stock forecast: see what analysts think of BOSTON SCIENTIFIC and suggest that you do with its stocks.
BSX stock is 2.26% volatile and has beta coefficient of 0.75. Track BOSTON SCIENTIFIC stock price on the chart and check out the list of the most volatile stocks — is BOSTON SCIENTIFIC there?
Today BOSTON SCIENTIFIC has the market capitalization of 117.54 B, it has increased by 2.23% over the last week.
Yes, you can track BOSTON SCIENTIFIC financials in yearly and quarterly reports right on TradingView.
BOSTON SCIENTIFIC is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.53 CHF per share, whereas the estimation was 0.50 CHF resulting in a 7.08% surprise. The estimated earnings for the next quarter are 0.58 CHF per share. See more details about BOSTON SCIENTIFIC earnings.
BOSTON SCIENTIFIC revenue for the last quarter amounts to 3.57 B CHF, despite the estimated figure of 3.42 B CHF. In the next quarter, revenue is expected to reach 3.89 B CHF.
BSX net income for the last quarter is 397.44 M CHF, while the quarter before that showed 291.29 M CHF of net income which accounts for 36.44% change. Track more BOSTON SCIENTIFIC financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 48.00 K employees. See our rating of the largest employees — is BOSTON SCIENTIFIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOSTON SCIENTIFIC EBITDA is 3.27 B CHF, and current EBITDA margin is 23.71%. See more stats in BOSTON SCIENTIFIC financial statements.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOSTON SCIENTIFIC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOSTON SCIENTIFIC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOSTON SCIENTIFIC stock shows the strong buy signal. See more of BOSTON SCIENTIFIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.